Chen Lin
Impact in
-
- Cancer Genomics and Diagnostics
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 4
- CAR-T cell therapy research 3
- Co-authors
- Yangqiu Li (5 shared papers)Shanshan Wang (2 shared papers)Yu Gan (2 shared papers)Jianhua Chang (2 shared papers)Xinmin Yu (1 shared paper)Jun Zhao (1 shared paper)Xun Shi (1 shared paper)Qiong He (1 shared paper)
- Journals
- BioMed Research International (2 papers)Cancer Cell International (2 papers)Cancer Biology & Therapy (1 paper)The Review of Corporate Finance Studies (1 paper)Transactions of the Royal Society of Tropical Medicine and Hygiene (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Chen Lin
20 papers receiving 328 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 62
- Pulmonary and Respiratory Medicine 121
- Oncology 88
- Hematology 26
- Finance 20
Countries citing papers authored by Chen Lin
This map shows the geographic impact of Chen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Lin more than expected).
Fields of papers citing papers by Chen Lin
This network shows the impact of papers produced by Chen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Lin. The network helps show where Chen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 76 | |
| 2 | 2016 | 51 | |
| 3 | 2015 | 43 | |
| 4 | 2010 | 30 | |
| 5 | 2013 | 28 | |
| 6 | 2015 | 24 | |
| 7 | 2012 | 16 | |
| 8 | Acorus tatarinowii Schott extract protects PC12 cells from amyloid-beta induced neurotoxicity. | 2014 | 16 |
| 9 | 2013 | 10 | |
| 10 | 2013 | 8 | |
| 11 | 2013 | 7 | |
| 12 | 2017 | 7 | |
| 13 | 2009 | 5 | |
| 14 | 2007 | 5 | |
| 15 | 2014 | 3 | |
| 16 | Hybrid particle swarm optimization for economic dispatch with valve-point effect | 2009 | 2 |
| 17 | 2012 | 2 | |
| 18 | 1989 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2023 | 1 |
About Chen Lin
Chen Lin is a scholar working on Molecular Biology, Oncology, Hematology, Pulmonary and Respiratory Medicine and Accounting, having authored 22 papers that have together received 336 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (4 papers), CAR-T cell therapy research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Banking stability, regulation, efficiency (2 papers), Alzheimer's disease research and treatments (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Medicinal Plants and Neuroprotection (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Cancer Research (62 citations), Pulmonary and Respiratory Medicine (121 citations), Oncology (88 citations), Hematology (26 citations) and Finance (20 citations). Chen Lin has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yangqiu Li, Shanshan Wang, Yu Gan, Jianhua Chang, Xinmin Yu, Jun Zhao, Xun Shi, Qiong He, Ying Jin and Weiwei Xie. Their work appears in journals such as BioMed Research International, Cancer Cell International, Cancer Biology & Therapy, The Review of Corporate Finance Studies and Transactions of the Royal Society of Tropical Medicine and Hygiene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.